Shelley B. Thunen, Chief Financial Officer at RxSight, Inc. (RXST), sold 20,000 shares at $39.63 ($785K) on 2024-01-02, disclosed to the SEC on 2024-01-03.
Scheduled sale ($785k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.77 | 4,519 | $175K | 22.3% |
| 2 | $38.77 | 4,519 | $175K | 22.3% |
| 3 | $39.63 | 5,481 | $217K | 27.7% |
| 4 | $39.63 | 5,481 | $217K | 27.7% |
| Total | $39.24 avg | 20,000 | $785K | 100% |
| Filing → |
| RXST | SELL | 2024-05-02 | $1.0M | — | Filing → |
| RXST | SELL | 2024-04-02 | $1.9M | — | Filing → |
| RXST | SELL | 2024-03-05 | $1.1M | — | Filing → |